美国甲型H1N1流感疫苗安全性监测探析与思考

中国药物警戒 ›› 2011, Vol. 8 ›› Issue (12): 725-728.

美国甲型H1N1流感疫苗安全性监测探析与思考

王丹, 董铎, 王亚丽, 侯永芳, 王春婷, 刘翠丽

国家食品药品监督管理局药品评价中心,北京 100045

收稿日期:2011-05-24 出版日期:2011-12-10 发布日期:2015-07-30
作者简介:王丹,女,副主任药师,药物警戒、药事管理。

Safety Monitoring of Influenza A（H1N1）Vaccine in US

WANG Dan, DONG Duo, WANG Ya-li, HOU Yong-fang, WANG Chun-ting, LIU Cui-li

Center for Drug Reevaluation, SFDA, Beijing 100045, China

Received:2011-05-24 Online:2011-12-10 Published:2015-07-30

摘要/Abstract

摘要： 2009年甲型H1N1流感病毒暴发流行以来,各国均开展了甲型H1N1流感疫苗免疫接种工作。本文通过探讨美国政府针对免疫接种后疫苗安全性监测所采取的措施,比较我国与美国在疫苗不良事件监测工作中存在的差距,为我国药物警戒工作的深入发展提供借鉴。

关键词: 甲型H1N1流感疫苗, 安全性监测, 疫苗不良事件

Abstract: Vaccination campaigns were initiated in many countries after 2009 H1N1 influenza pandemic had occurred. This article will discuss the activities of safety monitoring after immunization at the level of US governments, to compare the difference between the US and China in adverse events monitoring and provide reference for the profound development of China pharmacovigilance.

Key words: Influenza A(H1N1)vaccine, safety monitoring, vaccine adverse events

中图分类号:

王丹, 董铎, 王亚丽, 侯永芳, 王春婷, 刘翠丽. 美国甲型H1N1流感疫苗安全性监测探析与思考[J]. 中国药物警戒, 2011, 8(12): 725-728.

WANG Dan, DONG Duo, WANG Ya-li, HOU Yong-fang, WANG Chun-ting, LIU Cui-li. Safety Monitoring of Influenza A（H1N1）Vaccine in US[J]. Chinese Journal of Pharmacovigilance, 2011, 8(12): 725-728.

参考文献

[1] US CDC. H1N1 Presentation for Immunization Update 2010[EB/OL].2010-07-27[2011-05-12].http://www.cdc.gov/h1n1flu/imm_update_transcript.htm.
[2] US CDC. The 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010[EB/OL]. 2010-6-16[2011-05-12].http://www.cdc.gov/h1n1flu/cdcresponse.htm.
[3] HHS. Federal Plans to Monitor Immunization Safety for the Pandemic 2009 H1N1 Influenza Vaccination Program[EB/OL]. [2011-05-12].http://www.flu.gov/professional/federal/monitor_immunization_safety.html.
[4] US CDC. Summary of 2009 Monovalent H1N1 Influenza Vaccine Data Vaccine Adverse Event Reporting System[EB/OL]. 2010-05-29[2011-05-18].http://vaers.hhs.gov/resources/2010H1N1Summary_June03.pdf.
[5] Vellozzi C,. Adverse events following influenza A(H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System[J]. Vaccine.,2010 .28(45):7248-7255.
[6] Board on Population Health and Public Health Practice. Immunization Safety Review: Influenza Vaccines and Neurological Complications[EB/OL]. [2011-05-18]. http://iom.edu/Reports/2003/Immunization-Safety-Review-Influenza-Vaccines-and-Neurological-Complications.aspx.
[7] CDR.药物警戒快讯.[EB/OL].[2011-05-11].http://www.cdr.gov.cn/gxzy/_ywjjkx_/2009n/01/13108.shtml.
[8] US.CDC. Vaccine Safety Datalink(VSD) Project[EB/OL]. http://www.cdc.gov/vaccinesafety/Activities/VSD.html.
[9] VSRAWG. Report on 2009 H1N1 Vaccine Safety Risk Assessment-June 2010[EB/OL]. 2010-07[2011-06-12]. http://www.hhs.gov/nvpo/nvac/reports/vsrawg_repot_may2010.html.
[10] FDA&CDC. Archived Updates[EB/OL]. [2011-06-12].http://vaers.hhs.gov/resources/updates.
[11] 中国疾病预防控制中心. 国疾病预防控制中心充分做好甲型H1N1流感网络直报准备工作[EB/OL].2009-05-02[2011-05-15]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohwsyjbgs/s9992/200905/40366.htm.
[12] 梁晓峰.中国甲型流感（H1N1）疫苗上市后监测的安全性[N].中国医学论坛报,2011-02-24.